Atlas Trials

Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects

Clinical trial NCT02084953 · COMPLETED

Trial details

NCT number
NCT02084953
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2014-04-01
Primary completion
2014-05-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.